Vol. 19 No. 1 (2015)
CASE REPORTS

Emery Dreifuss progressive muscular dystrophy: cardiac pacing for primary prevention of sudden cardiac death

PDF (Русский)
  • S. Mironovich,
  • A. Shestak,
  • D. Podolyak,
  • Ye. Zaklyazminskaya,
  • S. Dzemeshkevich
S. Mironovich
B. Petrovsky Russian Research Center of Surgery
Bio
A. Shestak
B. Petrovsky Russian Research Center of Surgery
Bio
D. Podolyak
B. Petrovsky Russian Research Center of Surgery
Bio
Ye. Zaklyazminskaya
B. Petrovsky Russian Research Center of Surgery
Bio
S. Dzemeshkevich
B. Petrovsky Russian Research Center of Surgery
Bio
DOI: https://doi.org/10.21688/1681-3472-2015-1-104-109

Published 2015-10-10

Keywords

  • LAMINOPATHY,
  • BRADYARRHYTHMIA,
  • EMERY DREIFUSS PROGRESSIVE MUSCULAR DYSTROPHY,
  • CARDIAC PACING,
  • DNA-DIADNOSTICS,
  • LMNA
    • ...More
    Less

How to Cite

Mironovich, S., Shestak, A., Podolyak, D., Zaklyazminskaya, Y., & Dzemeshkevich, S. (2015). Emery Dreifuss progressive muscular dystrophy: cardiac pacing for primary prevention of sudden cardiac death. Patologiya Krovoobrashcheniya I Kardiokhirurgiya, 19(1), 104–109. https://doi.org/10.21688/1681-3472-2015-1-104-109

Copyright (c) 2015 Mironovich S.A., Shestak A.G., Podolyak D.G., Zaklyazminskaya Ye.V., Dzemeshkevich S.L.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Abstract

Permanent cardiac pacing is the only effective method for treating bradyarrhythmias and conduction disturbances of the heart, as well as for preventing the most severe complication of the disease - sudden cardiac death. We present the description of a family with Emery Dreifuss muscular dystrophy and progressive cardiac conduction disturbances, as well as the results of clinical examination of the family and surgical treatment. A new rare genetic variant s.513 + 45T>G in the LMNA gene, potentially violating mRNA splicing, was identified. The precise etiologic diagnosis of bradyarrhythmias, timely examination of family members and determination of optimal timing for pacemaker implantation require an integrating approach and accounting of clinical, electrophysiological and genetic factors.
PDF (Русский)

References

  1. Клиническая аритмология / Под ред. проф. А.В. Ардашева. М.: МЕДПРАКТИКА-М, 2009. 579 с.
  2. Emery A.E. Emery-Dreifuss muscular dystrophy -a 40 year retro-spective. Neuromuscular Disorders. 2000 Jun. Vol. 10 (4-5). P. 228-32.
  3. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death.
  4. Available at: http://www.ncbi.nlm.nih.gov/books/NBK1436/
  5. Yates J.R., Wehnert M. The Emery-Dreifuss Muscular Dystrophy Mutation Database. Neuromuscular Disorders. 1999 May. Vol. 9 (3). P. 199.
  6. Малашичева А.Б., Забирник А.С. и др. Мутации в гене ламина А/С изменяют дифференцировочный потенциал стромальных клеток жировой ткани // Цитология. 2013. Т. 55 (5). С. 313-17.
  7. Bonne G., Mercuri E., Muchir A. et al. Clinical and molecular genetic spectrum of auto-somal dominant Emery-Dreifuss muscular dystrophy due to mutations of the lamin A/C gene // Annals of neurology. 2000 Aug. Vol. 48 (2). P. 170-80.
  8. Komaki H., Hayashi Y.K., Tsuburaya R. et al. Inflammatory changes in infantile-onset LMNA-associated myopathy // Neuromuscul. Disorders. 2011. Aug. Vol. 21 (8). P. 563-68.
  9. Fidziańska A., Toniolo D., Hausmanowa-Petrusewicz I. Ultra-structural abnormality of sarcolemmal nuclei in Emery-Dreifuss muscular dystrophy (EDMD) // The Journal of the Neurological Sciences. 1998 Jul. 15. Vol. 159 (1). P. 88-93.